The Scientific World Journal / 2012 / Article / Tab 1

Research Article

A Neutral Risk on the Development of New-Onset Diabetes Mellitus (NODM) in Taiwanese Patients with Dyslipidaemia Treated with Fibrates

Table 1

Descriptive characteristics of fibrate prescriptions in the population, 2005–2010.

CharacteristicsNODMNo-NODMTotal 𝑃 -value
𝑛 % 𝑛 % 𝑛 %

Total1453.83,67096.23,815100
Age (year, mean ± SD) 5 6 . 1 0 ± 1 2 . 2 1 5 5 . 5 7 ± 1 2 . 5 6 5 5 . 5 9 ± 1 2 . 5 4 0.616
Gender
 Female5840.001,37237.381,43037.480.523
 Male8760.002,29862.622,38562.52
Drug group
 Fenofibrate10471.722,70273.622,80673.550.611
 Gemfibrozil4128.2896826.381,00926.45
Mean dose
 Fenofibrate 2 6 2 . 1 7 ± 2 3 8 . 5 0 2 2 2 . 0 3 ± 1 5 2 . 5 2 2 2 3 . 5 2 ± 1 5 6 . 6 7 0.048
 Gemfibrozil 7 0 3 . 9 0 ± 3 2 8 . 4 6 6 3 7 . 4 4 ± 3 2 3 . 3 4 6 4 0 . 1 4 ± 3 2 3 . 6 5 0.198

Differences in continuous variables were analysed using the unpaired student’s t-test.
Categorical variables were analysed using by either Fisher’s exact test or the chi-squared test.